Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received NOC (Notice of Compliance) from Health Canada for ZDS-Varenicline tablets
In a move that blends generative AI with healthcare delivery, ekincare has announced the launch of elva.AI, an always-on, intelligent Gen-AI assistant designed to deliver instant, personalized support across pharmacy, checkups, reimbursements...
The Pharma Manufacturing and Automation Convention 2025 is about to take place on October 8 and 9, at Hotel Novotel HICC, Hyderabad. This two-day event will unite pharma innovators, leaders in Mfg and digital visionaries to recreate the manner...
Roche reported positive five-year effectiveness, safety, and durability data for Susvimo (ranibizumab injection) for the treatment of neovascular or "wet" age-related macular degeneration (nAMD) from the Phase III Portal study, a long-term extension
.png)
In a major leap forward for migraine treatment, Cadila Pharmaceuticals has launched Vasograin Plus, a powerful dual-action therapy for the acute treatment of migraine, with or without aura, in adults and adolescents.This cutting-edge...
STEER World, a global leader in materials transformation technology, today announced through its Lifesciences arm, STEERLife, a novel platform for advanced ingredient solutions.
Gujarat Chief Minister, Bhupendra Patel, opened the 20th edition of Pharma & Labtech Expo 2025 at the Helipad Exhibition Centre in Gandhinagar with State Health Minister Rishikesh Patel.
Intas Pharmaceuticals, a prominent multinational company specializing in pharmaceutical formulation development, manufacturing, and marketing, has introduced Hetronifly (serplulimab) in the Indian market. This product is the first PD-1 inhibitor to
In a significant step for the pharmaceutical industry, the National Pharmaceutical Pricing Authority (NPPA) has revised ceiling prices for four critical formulations listed under the National List of Essential Medicines (NLEM), 2022, bringing down...
The associations of drug control officers across the nation have strongly opposed the Karnataka health minister's reported statement on involving the Quality Council of India (QCI) as a third-party agency for monitoring medicine quality
.jpg)
, CDSCO.jpg)